Simvastatin BSA Conjugate

<strong>Simvastatin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020685_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> simvastatin-BSA complex, simvastatin-bovine serum albumin conjugate, simvastatin-BSA adduct, simvastatin-BSA derivative, simvastatin bound to BSA, simvastatin-BSA hybrid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kearney, P. M., Blackwell, L., Collins, R., et al. (2008). Efficacy of statins in the primary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials. *European Heart Journal*, 29(23), 3006-3015._x000D_ _x000D_ 2. Baigent, C., Keech, A., Kearney, P. M., et al. (2005). Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statin therapy. *Lancet*, 366(9493), 1267-1278._x000D_ _x000D_ 3. Collins, R., Armitage, J., Parish, S., et al. (2004). Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in men and women with cerebrovascular disease: a randomized controlled trial. *Lancet*, 363(9411), 757-767._x000D_ _x000D_ 4. Sacks, F. M., Pfeffer, M. A., Moye, L. A., et al. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. *New England Journal of Medicine*, 335(14), 1001-1009._x000D_ _x000D_ 5. Ridker, P. M., Danielson, E., Fonseca, F. A. H., et al. (2009). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. *New England Journal of Medicine*, 359(21), 2195-2207._x000D_ _x000D_ 6. Law, M. R., Wald, N. J., and Rudnicka, A. R. (2003). Quantifying effect of statins on low density lipoprotein cholesterol and coronary heart disease: a systematic review and meta-analysis. *BMJ*, 326(7404), 1423._x000D_ _x000D_ 7. Liao, J. K., and Laufs, U. (2005). Pleiotropic effects of statins. *Annual Review of Pharmacology and Toxicology*, 45, 89-118._x000D_ _x000D_ 8. Kearney, P. M., Blackwell, L., Collins, R., et al. (2008). Efficacy of statins in the primary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials. *European Heart Journal*, 29(23), 3006-3015._x000D_ _x000D_ 9. Haffner, S. M., and Stern, M. P. (1997). Epidemiology of type 2 diabetes and its cardiovascular implications. *Journal of Cardiovascular Risk*, 4(1), 7-11._x000D_ _x000D_ 10. Gotto, A. M., and Pownall, H. J. (2002). The role of statins in the management of dyslipidemia. *American Journal of Cardiology*, 90(8), 1-6._x000D_ <a href="Simvastatin">https://pubmed.ncbi.nlm.nih.gov/?term=Simvastatin BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Simvastatin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>